Trial intelligence / Profile preview

Yunnan Baiyao Capsules for Limb Swelling After Periankle Fracture

ChiCTR2500103255Phase 4Not yet recruiting

Sponsor
Shenzhen University General Hospital
Start
May 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in ankle fracture comparing Yunnan Baiyao Capsules treatment group with Placebo group (2 arms). Primary endpoint: Swelling measurement on postoperative day 7. Planned start May 2025; status: not yet recruiting.

02

Drugs

Yunnan Baiyao
03

Conditions

ankle fracture

Beyond the preview

Go deeper on ChiCTR2500103255.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2500103255.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call